Find Clinical Trials | Cedars-Sinai

5 results found

Movement Disorders, Parkinson's Disease

Boundless

This study focuses on individuals who have Parkinson's disease with poorly controlled or involuntary movement symptoms. The purpose of the study is to evaluate the effectiveness and safety of an investigational drug called ND0612, delivered ...

Movement Disorders, Parkinson's Disease

Intravenous Prasinezumab in Early Parkinson's Disease

The purpose of this study is to compare the effects of an experimental drug called prasinezumab in patients with early Parkinson's disease who are taking standard medication (either rasagiline, selegiline, or levodopa) to manage their ...

Movement Disorders, Parkinson's Disease

BIIB122 in Parkinson's Disease

This study will evaluate whether an investigational drug called BIIB122 is safe and effective in people with early-stage Parkinson’s disease (PD) who are 30-80 years old. The study also aims to learn how the body ...

Normal Cognition, Mild cognitive impairment (MCI), Alzheimer's disease, Dementia with ...

GOAL and RAPID Studies

GOAL and RAPID Studies: Purpose: The purpose of these studies is to identify biological, environmental, social, and behavioral factors that influence risk for or protection against age-related cognitive decline and Alzheimer's Disease and Related Dementias (ADRD). The ...

Parkinson's Disease

TEMPO-4 Trial

This study focuses on individuals who are 40-80 years old and have been diagnosed with Parkinson's disease. The purpose of the study is to determine the safety and effectiveness of an investigational drug called CVL-751 ...